Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | TPD52L2 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-09 |
mRNA | MCFD2 | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-09 |
mRNA | FAM209A | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | CASP8AP2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-09 |
mRNA | KIF1A | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | C2CD4C | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |